Skip to content

A clinical trial to compare dexmedetomidine or propofol with combination of scalp block on hemodynamic and postoperative recovery parameter in chronic subdural hematoma surgery

Comparative evaluation of dexmedetomidine or propofol along with scalp block on haemodynamic and postoperative recovery for chronic subdural haematoma evacuation under monitored anaesthesia care

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/01/005478
Enrollment
50
Registered
2015-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Burr hole for chronic subdural hematoma patients

Interventions

Intervention1: Propofol: Propofol loading dose 1mg/kg over 10 minutes, followed by maintenance infusion at a rate of 1-3 mg/kg/h Control Intervention1: Dexmedetomidine: Dexmedetomidine loading dose 1

Sponsors

Apollo Hospitals Bilaspur CG India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA grade I and III, 2. Scheduled for surgery under scalp block

Exclusion criteria

Exclusion criteria: 1.Patients with known sensitivity to study drugs 2.Glasgow coma scale 3.history of drug or alcohol abuse, 4.history of chronic pain or daily intake of analgesics 5.Oral anticoagulant use (warfarin) 6.Patients with bleeding diathesis 7.impaired kidney or liver functions and 8.psychiatric patients

Design outcomes

Primary

MeasureTime frame
Hemodynamic parameter (blood pressure and heart rate) and oxygen saturaionTimepoint: Preop, After study drug, intraop period, postop period

Secondary

MeasureTime frame
Patient and Surgeon satisfaction, postoperative recovery parameterTimepoint: Postoperative period

Countries

India

Contacts

Public ContactDr Vinit Kumar Srivastava

Apollo Hospitals Bilaspur (C.G.) India

drvinit75@gmail.com9755557539

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026